European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

MT Newswires Live00:16

European equities traded in the US as American depositary receipts were tracking higher late Wednesday morning, rising 1% to 1,860.69 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which advanced 11% and 6.3% respectively. They were followed by lender Banco Santander (SAN) and biopharmaceutical company DBV Technologies (DBVT), which increased 4.2% and 2.2% respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk (NVO) and brewing company Anheuser-Busch InBev (BUD), which dropped 2.3% and 2.2% respectively. They were followed by consumer goods company Unilever (UL) and biotech firm Evaxion (EVAX), which lost 1.6% and 0.6% respectively.

From the UK and Ireland, the gainers were led by lender HSBC (HSBC) and mining company BHP Group (BHP), which rose 6.9% and 3.1% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Mereo BioPharma Group (MREO), which were up 2.2% and 1.6% respectively.

The decliners from the UK and Ireland were led by alcoholic beverage company Diageo (DEO) and biopharmaceutical company Amarin (AMRN), which fell 13.4% and 10.2% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and hospitality company InterContinental Hotels Group (IHG), which were down 0.9% and 0.7% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment